Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedrich Haag

Showing results (111-120 of 143) with videos related to

Pageof 15
Sort By:
Purinergic Signalling|April 25, 2019
P2X7-mediated ATP secretion is accompanied by depletion of cytosolic ATPBjarne Johnsen, Klaus Eric Kaschubowski, Sorush Nader, et al.
Scientific Reports|March 11, 2015
Tuning IL-2 signaling by ADP-ribosylation of CD25Sophie Teege, Alexander Hann, Maria Miksiewicz, et al.
Frontiers in Immunology|April 9, 2024
Generation and characterization of antagonistic anti-human CD39 nanobodiesStephan Menzel, Yinghui Duan, Julia Hambach, et al.
Scientific Reports|November 30, 2017
Ecto-ADP-ribosyltransferase ARTC2.1 functionally modulates FcγR1 and FcγR2B on murine microgliaBjörn Rissiek, Stephan Menzel, Mario Leutert, et al.
Frontiers in Medicine|June 30, 2023
Non-organ-specific autoantibodies with unspecific patterns are a frequent para-infectious feature of chronic hepatitis DLennart Hermanussen, Sibylle Lampalzer, Jan-Hendrik Bockmann, et al.
Pathogens (Basel, Switzerland)|September 19, 2020
Significance of Anti-Nuclear Antibodies and Cryoglobulins in Patients with Acute and Chronic HEV InfectionThomas Horvatits, Julian Schulze Zur Wiesch, Susanne Polywka, et al.
Frontiers in Immunology|October 25, 2023
Immunosuppressive M2 TAMs represent a promising target population to enhance phagocytosis of ovarian cancer cells <i>in vitro</i>Franziska Brauneck, Leticia Oliveira-Ferrer, Jana Muschhammer, et al.
Clinical & Developmental Immunology|December 23, 2011
Patients with multiple myeloma develop SOX2-specific autoantibodies after allogeneic stem cell transplantationSebastian Kobold, Sinje Tams, Tim Luetkens, et al.
Cancer Immunology, Immunotherapy : CII|August 1, 2014
Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantationTim Luetkens, Sebastian Kobold, Yanran Cao, et al.
Journal of Leukocyte Biology|February 15, 2017
Down-regulation of CD73 on B cells of patients with viremic HIV correlates with B cell activation and disease progressionEun-Seong Kim, Christin Ackermann, Ilona Tóth, et al.
Pageof 15

Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
Purinergic Signalling|April 25, 2019
P2X7-mediated ATP secretion is accompanied by depletion of cytosolic ATPBjarne Johnsen, Klaus Eric Kaschubowski, Sorush Nader, et al.
Scientific Reports|March 11, 2015
Tuning IL-2 signaling by ADP-ribosylation of CD25Sophie Teege, Alexander Hann, Maria Miksiewicz, et al.
Frontiers in Immunology|April 9, 2024
Generation and characterization of antagonistic anti-human CD39 nanobodiesStephan Menzel, Yinghui Duan, Julia Hambach, et al.
Scientific Reports|November 30, 2017
Ecto-ADP-ribosyltransferase ARTC2.1 functionally modulates FcγR1 and FcγR2B on murine microgliaBjörn Rissiek, Stephan Menzel, Mario Leutert, et al.
Frontiers in Medicine|June 30, 2023
Non-organ-specific autoantibodies with unspecific patterns are a frequent para-infectious feature of chronic hepatitis DLennart Hermanussen, Sibylle Lampalzer, Jan-Hendrik Bockmann, et al.
Pathogens (Basel, Switzerland)|September 19, 2020
Significance of Anti-Nuclear Antibodies and Cryoglobulins in Patients with Acute and Chronic HEV InfectionThomas Horvatits, Julian Schulze Zur Wiesch, Susanne Polywka, et al.
Frontiers in Immunology|October 25, 2023
Immunosuppressive M2 TAMs represent a promising target population to enhance phagocytosis of ovarian cancer cells <i>in vitro</i>Franziska Brauneck, Leticia Oliveira-Ferrer, Jana Muschhammer, et al.
Clinical & Developmental Immunology|December 23, 2011
Patients with multiple myeloma develop SOX2-specific autoantibodies after allogeneic stem cell transplantationSebastian Kobold, Sinje Tams, Tim Luetkens, et al.
Cancer Immunology, Immunotherapy : CII|August 1, 2014
Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantationTim Luetkens, Sebastian Kobold, Yanran Cao, et al.
Journal of Leukocyte Biology|February 15, 2017
Down-regulation of CD73 on B cells of patients with viremic HIV correlates with B cell activation and disease progressionEun-Seong Kim, Christin Ackermann, Ilona Tóth, et al.
Pageof 15